Keyphrases
Obesity
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
100%
Semaglutide
100%
Clinical Summary
57%
Kansas City Cardiomyopathy Questionnaire
57%
Heart Failure
42%
6-minute Walk Distance (6MWD)
42%
Placebo
28%
Living with
28%
Reduced Body
28%
Left Ventricular Ejection Fraction
28%
C-reactive Protein
28%
Hierarchical Composite Endpoints
28%
Semaglutide 2.4 Mg
28%
Heart Failure Symptoms
14%
Patients with Heart Failure
14%
Treatment Effect
14%
Atrial Fibrillation
14%
Body Mass Index
14%
Coronary Artery Disease
14%
All-cause Mortality
14%
Serious Adverse Events
14%
Baseline Characteristics
14%
Type 2 Diabetic Patients
14%
Physical Limitations
14%
Physical Exercise
14%
Heart Failure Events
14%
Change Score
14%
Patients with Obesity
14%
High Body Mass Index
14%
Changes in Body Weight
14%
Distance Changes
14%
Exercise Function
14%
Once-weekly Semaglutide
14%
Medicine and Dentistry
Heart Failure with Preserved Ejection Fraction
100%
Semaglutide
100%
Congestive Heart Failure
55%
Myocardial Disease
44%
Body Weight
33%
Walking Distance
33%
Heart Left Ventricle Ejection Fraction
22%
Body Mass Index
22%
C Reactive Protein
22%
Placebo
22%
Coronary Artery Disease
11%
Atrial Fibrillation
11%
Adverse Event
11%
Patient with Type 2 Diabetes
11%
Patient with Obesity
11%
Treatment Effect
11%
Nursing and Health Professions
Heart Failure with Preserved Ejection Fraction
100%
Semaglutide
100%
Congestive Heart Failure
55%
Myocardial Disease
44%
Walking Distance
33%
Body Weight
33%
Body Mass
22%
Placebo
22%
C Reactive Protein
22%
Heart Left Ventricle Ejection Fraction
22%
Patient with Obesity
11%
Patient with Type 2 Diabetes
11%
Adverse Event
11%
Coronary Artery Disease
11%
Atrial Fibrillation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure with Preserved Ejection Fraction
100%
Semaglutide
100%
Congestive Heart Failure
55%
Myocardial Disease
44%
Placebo
22%
C Reactive Protein
22%
Coronary Artery Disease
11%
Adverse Event
11%
Heart Left Ventricle Failure
11%
Atrial Fibrillation
11%
Non Insulin Dependent Diabetes Mellitus
11%